The high leptin group demonstrated substantially worse metabolic parameters across all domains, including glycemic control, lipid profiles, and blood pressure, resulting in higher metabolic syndrome prevalence (91% vs. 84%, p = 0.008). The gene discussed is LEP; the disease is metabolic syndrome.